Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI
Clinical trial NCT02066870 · UNKNOWN
Trial details
- NCT number
- NCT02066870
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-09-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.